Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: Role in β-cell adaptation and failure in the etiology of diabetes

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  Prentki, Marc ^a,b   Joly, Erik ^a   El Assaad, Wissal ^a   Roduit, Raphaël ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FATTY ACID; GLUCOSE; MALONYL COENZYME A; PEROXISOME PROLIFERATOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

CONFERENCE PAPER; CYTOTOXICITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036896505     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s405     Document Type: Conference Paper

References (85)

1. Kahn CR: Insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes 43:1066-1084, 1994
2. Poitout V, Robertson RP: An integrated view of beta cell dysfunction in type 2 diabetes. Annu Rev Med 47:69-83, 1996
3. Porte D: β-cells in type 2 diabetes mellitus. Diabetes 40:166-180, 1991
4. Assimacopoulos-Jeannet F, Jeanrenaud B: The hormonal and metabolic basis of experimental obesity. Clin Endocrinol Metab 5:337-365, 1976
5. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45:3-10, 1996
6. Prentki M, Corkey BE: Are the beta-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
7. Ruderman NB, Saha AK, Vavvas D, Witters LA: Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276: E1-E18, 1999
8. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770, 1992
9. Hansen BC, Bodkin NL: Beta-cell hyperresponsiveness: Earliest event in development of diabetes in monkeys. Am J Physiol 259:R612-R617, 1990
10. Polonsky KS, Sturis J, Bell GI: Non-insulin dependent diabetes mellitus: A genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777-783, 1996
11. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569, 1998
12. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: Evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
13. Bergman RN, Ader M: Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 11:351-356, 2000
14. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43:613-621, 1994
15. Ogawa Y, Noma Y, Davalli AM, Wu YJ, Thorens B, Bonner-Weir S, Weir GC: Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted beta-cells. Diabetes 44:75-79, 1995
16. Unger RH, Grundy S: Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implication for the management of diabetes. Diabetologia 28:118-121, 1985
17. Leahy JL, Bonner-Weir S, Weir GC: Beta-cell dysfunction induced by chronic hyperglycemia: Current ideas on mechanism of impaired glucoseinduced insulin secretion. Diabetes Care 15:442-455, 1992
18. Liang Y, Buettger C, Berner DK, Matschinsky FM: Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (βHC9). Diabetologia 40:1018-1027, 1997
19. Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, Lewis GF, Giacca A: Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524-530, 1999
20. Segall L, Lameloise N, Assimacopoulos-Jeannet F, Roche E, Corkey P, Thumelin S, Corkey BE, Prentki M: Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am J Physiol 277:E521-E528, 1999
21. Bollheimer C, Skelly RH, Chester MW, McGarry JD, Rhodes C: Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094-1101, 1998
22. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH: Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats: Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487-32490, 1998
23. Prentki M, Segall L, Roche E, Thumelin S, Brun T, McGarry JD, Corkey BE, Assimacopoulos-Jeannet F: Gluco-lipotoxicity and gene expression in the pancreatic beta cell. In Journées de Diabétologie Hotel-Dieu 1988. Paris, Médecine-Sciences, Flammarion. 1998, p. 17-27
24. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM: The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 109: S189-S201, 2001
25. Poitout V, Robertson RP: Secondary beta-cell failure in type 2 diabetes: A convergence of glucotoxicity and lipotoxicity (Minireview). Endocrinology 143:339-342, 2002
26. Linn T, Strate C, Schneider K: Diet promotes beta-cell loss by apoptosis in prediabetic nonobese diabetic nuce. Endocrinology 140:3767-3773, 1999
27. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20:649-688, 1999
28. Unger RH: How obesity causes diabetes in Zucker Diabetic Fatty rats. Trends Endocrinol Metab 7:276-282, 1997
29. Beales PE, Liddi R, Giorgini AE, Signore A, Procaccini E, Batchelor K, Pozzilli P: Troglitazone prevents insulin dependent diabetes in the nonobese diabetic mouse. Eur J Pharmacol 357:221-225, 1998
30. Issa-Chergui B, Guttmann RD, Seemayer TA, Kelley VE, Colle E: The effect of diet on the spontaneous insulin dependent diabetic syndrome in the rat. Diabetes Res 9:81-86, 1988
31. Lefkowith J, Schreiner G, Cornuer J, Handler ES, Driscoll HK, Greiner D, Mordes JP, Rossini AA: Prevention of diabetes in the BB rat by essential fatty acid deficiency: Relationship between physiological and biochemical changes. J Exp Med 171:729-743, 1990
32. Baum JD, Ounsted M, Smith MA: Weight gain in infancy and subsequent development of diabetes mellitus in childhood (Letter). Lancet ii:866, 1975
33. Johansson C, Samuelsson U, Ludvigsson J: A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37:91-94, 1994
34. Shimabukuro M, Koyama K, Lee Y, Unger RH: Leptin- or troglitazoneinduced lipopenia protects islets from interleukin 1beta cytotoxicity. J Clin Invest 100:1750-1754, 1997
35. Jindal RM: Post-transplant hyperlipidaemia. Postgrad Med J 73:785-793, 1997
36. Pouteil-Noble C, Guebre F: [Effect of immunosuppressants on lipids]. Nephrologie 21:369-372, 2000
37. Duijnhoven E, Boots J, Christiaans M, Wolffenbuttel B, Hooff J: Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study. J Am Soc Nephrol 12:583-588, 2001
38. Marchetti P, Navalesi R: The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest 23:482-490, 2000
39. Shapiro AM, Ryan EA, Lakey JR: Clinical islet transplant: State of the art. Transplant Proc 33:3502-3503, 2001
40. Efanova IB, Zaitsev SV, Zhivotovsky B, Kohler M, Efendic S, Orrenius S, Berggren PO: Glucose and tolbutamide induce apoptosis in pancreatic beta-cells: A process dependent on intracellular Ca2+ concentration. J Biol Chem 273:33501-33507, 1998
41. Hoorfar J, Buschard K, Brogren CH: Impact of dietary protein and fat source on the development of insulin-dependent diabetes in the BB rat. Diabetes Res 20:33-41, 1992
42. Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744, 1999
43. Lee Y, Hirose H, Zhou YT, Esser V, McGarry JD, Unger RH: Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesis of NIDDM. Diabetes 46:408-413, 1997
44. Shimabukaro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 94:4637-4641, 1997
45. Prentki M: New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur J Endocrinol 134:272-286, 1996
46. Prentki M, Tornheim K, Corkey BE: Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40:S32-S41, 1997
47. Aizawa T, Komatsu M, Asanuma N, Sato Y, Sharp GW: Glucose action 'beyond ionic events' in the pancreatic beta cell. Trends Pharmacol Sci 19:496-499, 1998
48. Farfari S, Schulz V, Corkey B, Prentki M: Glucose regulated anaplerosis and cataplerosis in pancreatic β-cells: Possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 49:718-726, 2000
49. Deeney JT, Gromada J, Hoy M, Olsen HL, Rhodes CJ, Prentki M, Berggren PO, Corkey BE: Acute stimulation with long chain acyl-CoA enhances exocytosis in insulin-secreting cells (HIT T-15 and NMRI beta-cells). J Biol Chem 275:9363-9368, 2000
50. Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentki M: A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J Biol Chem 264:21608-21612, 1989
51. Farese RV, DiMarco PE, Barnes DE, Sabir MA, Larson RE, Davis JS, Morrison AD: Rapid glucose-dependent increases in phosphatidic acid and phosphoinositides in rat pancreatic islets. Endocrinology 118:1498-1503, 1986
52. Yaney GC, Korchak HM, Corkey BE: Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 141:1989-1998; 2000
53. Yajima H, Komatsu M, Yamada S, Straub SG, Kaneko T, Sato Y, Yamauchi K, Hashizume K, Sharp GW, Aizawa T: Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: A study in rat pancreatic islets. Diabetes 49:712-717, 2000
54. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB: Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. J Biol Chem 273:16146-16154, 1998
55. Mulder H, Lu D, Finley IV J, An J, Cohen J, McGarry JD, Newgard CB: Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) beta-cells. J Biol Chem 276: 6479-6484, 2001
56. Rubi B, Antinozzi PA, Herrero L, Ishihara H, Asins G, Serra D, Wollheim CB, Maechler P, Hegardt FG: Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: Effect on cell metabolism and insulin secretion. Biochem J 364:219-226, 2002
57. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M: A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: A study in hormone-sensitive lipase-deficient mice. Diabetes 50:1970-1975, 2001
58. Masiello P, Novelli M, Bombara M, Fierabracci V, Vittorini S, Prentki M, Bergamini E: The antilipolytic agent 3,5-dimethylpyrazole inhibits insulin release in response to both nutrient secretagogues and cyclic adenosine monophosphate agonists in isolated rat islets. Metabolism 51:110-114, 2002
59. Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 108:457-465, 2001
60. Maechler P, Wollheim CB: Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis [see comments]. Nature 402:685-689, 1999
61. MacDonald MJ: Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets: Further implication of cytosolic NADPH in insulin secretion. J Biol Chem 270:20051-20058, 1995
62. Lu D, Mulder H, Zhao P, Burgess SC, Jensen MV, Kamzolova S, Newgard CB, Sherry AD: 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci U S A 99:2708-2713, 2002
63. Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T: Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 272:3324-3329, 1997
64. Paumen MB, Ishida Y, Han H, Muramatsu M, Eguchi Y, Tsujimoto Y, Honjo T: Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2. Biochem Biophys Res Commun 231: 523-525, 1997
65. Colquhoun A: Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells. Biochem Mol Biol Int 45:331-336, 1998
66. Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M: Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic β-cell line INS-1. J Biol Chem 272:1659-1664, 1997
67. Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M: Long chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic β cell line INS-1. Diabetes 46:393-400, 1997
68. Pizer ES, Thupari J, Han WF, Pinn ML, Chrest FJ, Frehywot GL, Townsend CA, Kuhajda FP: Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 60:213-218, 2000
69. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317-1322, 1998
70. Berne C: The metabolism of lipids in mouse pancreatic islets: The biosynthesis of triacylglycerols and phospholipids. Biochem J 152:667-673, 1975
71. Brun T, Roche E, Assimacopoulos-Jeannet F, Corkey BE, Kim KH, Prentki M: Evidence for an anaplerotic malonyl-CoA pathway in pancreatic beta-cell nutrient signaling. Diabetes 45:190-198, 1996
72. Peter-Riesch B, Fathi M, Schlegel W, Wollheim CB: Glucose and carbachol generate 1,2-diacylglycerols by different mechanisms in pancreatic islets. J Clin Invest 81:1154-1161, 1988
73. Wolf BA, Easom RA, McDaniel ML, Turk J: Diacylglycerol synthesis de novo from glucose by pancreatic islets isolated from rats and humans. J Clin Invest 85:482-490, 1990
74. Prentki M, Matschinsky FM: Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248, 1987
75. Brun T, Roche E, Kim KH, Prentki M: Glucose regulates acetyl-CoA carboxylase gene expression in a pancreatic beta-cell line (INS-1). J Biol Chem 268:18905-18911, 1993
76. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, Brun T, Corkey BE, Saha AK, Prentki M: Long term exposure of β-INS cells to high glucose increases anaplerosis, lipogenesis and lipogenic gene expression. Diabetes 47:1086-1094, 1998
77. Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC: Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912-10921, 2002
78. Roduit R, Morin J, Massé F, Segall L, Roche E, Newgard CB, Assimacopoulos-Jeannet F, Prentki M: Glucose down regulates the expression of the PPARalpha gene in the pancreatic β-cell. J Biol Chem 275:35799-35806, 2000
79. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger RH: Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A 97:8536-8541, 2000
80. Liu YQ, Tornheim K, Leahy JL: Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes 47:1889-1893, 1998
81. Roche E, Assimacopoulos-Jeannet F, Witters LA, Perruchoud B, Corkey BE, Asfari M, Prentki M: Induction by glucose of genes coding for glycolytic enzymes in a pancreatic β-cell line (INS-1). J Biol Chem 272:3091-3098, 1997
82. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V: Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315-321, 2001
83. Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V: Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49:532-536, 2000
84. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96:10857-10862, 1999
85. Carlsson C, Borg LA, Welsh N: Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140:3422-3428, 1999